OVARIAN CANCER

(1), ovarian cancer-chemotherapy drug commonly used drug <BR> melphalan (PAM) 0.2 ^ / ㎏ d, oral, 4 ~ for a course on the 5th, rest four to six weeks after duplication. Thiotepa (161-169) 10 ^ / times, intramuscular or intravenous injection, used five times, every other day to once a total of 300 ~ 500 days for an induction course. 6 to 8 weeks under the condition repeat. Cyclophosphamide (CTX) 50 ~ 100 ^ / day, oral, 7 ~ 10 Tianyi treatment, two weeks after duplication. Or 400 ^ / day, intravenous, oral to four days. Adriamycin (ADM) 50 ~ 70 ^ / ㎡, intravenous injection. Every three weeks.
(2), and malignant ovarian tumor joint chemical treatment of ovarian cancer chemotherapy are better response. In recent years the chemical treatment of tumors faster progress in the treatment of ovarian cancer Habitat has an important place to improve the treatment of ovarian cancer play a positive role as a surgical adjuvant therapy, commonly used in the preoperative, intraoperative and postoperative, but often require a longer period of intermittent medication, and the human body toxicity also sometimes larger. In most cases, it is difficult to ovarian cancer surgery primary tumor and metastasis consider chemical treatment based treatment.

Tags: body, cancer, cases, chemotherapy, days, drug, eat, injection, intravenous, malignant, metastasis, ovarian, positive, response, surgery, surgical, therapy, time, toxicity, treatment, tumor, tumors

Common complications of ovarian cancer tumor rupture, hemorrhage, secondary infection, anemia, cancer of the intestine cancer and intestinal infarction colic.

Tags: abdominal, age, anti, benign, body, breast, cancer, carcinoma, cases, cause, cell, chemotherapy, cyst, cystic, cysts, diagnosis, early, eat, examination, gene, grams, increased, malignant, mass, ovarian, pain, patients, pelvic, response, risk, second, surgery, symptoms, syndrome, tea, therapy, time, treatment, tumor, tumors, usually, uterine, women

Disseminated and metastasis 1. Transfer of malignant ovarian tumor growth and metastasis, and other parts of the same direct spread of cancer, and the lymphatic and blood way. But the transfer spread mainly by direct more directly transferred to pots, abdominal organs and organizations, or transfer of Tai omentum, mesenteric, in a number of intraperitoneal nodular mass, a certain degree of mobility; Peritoneal or transferred to the pelvic floor in the vaginal fornix after palpation, palpable in the womb may have rectal Waterloo a papillary protrusions, even penetrating pelvic viscera, a sinus, and the rectum,; a vaginal or urethral cancer tissue from the pus and bleeding. Ovarian cancer found in the lymph node metastasis rate as high as 50%, or even transferred to the left supraclavicular lymph nodes, or perineum, is in the diagnosis and treatment of ovarian cancer, attention. 2. Common vicious invasion on the side of the fixed pelvic advanced malignant ovarian tumors, resulting in partial perivascular infiltration oppression, to the side of lower extremity venous disruption, edema formation. If the intestine of oppression by the vicious invasion, caused obstruction symptoms; Ureteral pressure, often the hydronephrosis. Phase I clinical Asia ovarian cancer metastasis Positions The number of cases Transfer rate (%)

Tags: abdominal, bleeding, blood, cancer, cases, cause, cell, cells, clinical, diagnosis, eat, ert, growth, intraperitoneal, lymph, malignant, mass, metastasis, node, oppression, ovarian, pelvic, rate, symptoms, treatment, tumor, tumors

Health, will be right recurrent ovarian cancer surgery and chemotherapy again whether there has been significant controversy. Fourth Military Medical University Xijing Hospital director of obstetrics and gynecology professor Detang, has nearly 10 years of the 38 treated patients with recurrent epithelial ovarian cancer clinical data were analyzed retrospectively after that, again recurrent ovarian cancer surgery and chemotherapy, can further improve the survival rate of patients.

Tags: cancer, cases, chemotherapy, clinical, early, eat, ovarian, patients, rate, surgery, survival, therapy, treatment, tumor, tumors

A scholar from the Netherlands led multinational collaborative research suggest that the early epithelial ovarian cancer surgical staging, can predict whether the patients have residual ovarian cancer and the need for postoperative adjuvant chemotherapy.

Tags: age, cancer, carcinoma, cases, cell, chemotherapy, cisplatin, clinical, early, examination, group, ovarian, patients, poor, prognosis, rate, residual, staging, surgery, surgical, survival, therapy, time, tumor

Despite preventive ovariectomy in the prevention of high-risk patients with ovarian cancer in a certain role, but still cautious, because ovarian cancer and distinguish the cavity cancer can occur. In one study, 16 of 28 high-risk family members to preventive ovariectomized later, three occurred, and diffuse abdominal cancer. These high-risk patients, and that the author: genetic susceptibility not only confined to the ovary, but also extends to occur in embryos with ovarian related organizations. Formerly, reported preventive nest after resection of 324 cases of women, six cases (1.8%) of the peritoneum of the original tumor. Therefore, the preventive after resection of primary ovarian peritoneal tumor, and less common, the incidence rate of about 2%.

Tags: abdominal, cancer, cases, cause, ert, family, gene, incidence, ovarian, ovary, patients, preventive, rate, resection, risk, study, tumor, women

Fourth Military Medical University Xijing Hospital maternity doctor completed a Biochemistry and the National Natural Science Foundation-funded projects that vascular endothelial growth factor in epithelial ovarian cancer and the formation of blood vessels play an important role.

Biochemistry and immunohistochemical methods used to detect 37 cases of epithelial ovarian cancer of vascular endothelial growth factor expression showed that ovarian cancer and vascular endothelial growth factor related. Therefore, the use of anti-vascular endothelial growth factor-card issuers ribozyme eukaryotic expression vector, in ovarian cancer-specific antibody-mediated tumor cell block under the vascular endothelial growth factor expression levels of genes in the treatment of ovarian cancer provides a strong basis.

Tags: anti, blood, body, cancer, cases, cell, eat, gene, growth, method, ovarian, treatment, tumor

Many female menstrual disorder is often encountered problems, including extending or shortening cycle, increased amount of bleeding, these belong to dysfunctional bleeding, referred to as DUB.

Women of childbearing age are generally more because luteal function well, resulting in menstrual disorders, which means although cycle, but the cycle will shorten, or more menstrual bleeding. Some 20 days to the first menstruation, it is because luteal function well. Similarly some may last 30 days, but rather a long time hemorrhage, which is bad because luteal function caused. While these cases more, but the problem is not very serious and <BR>, relatively speaking, not a great amount of bleeding.

Tags: age, bleeding, cancer, cases, cause, cyst, cystic, days, eat, ert, gene, grams, gynecological, increased, ovarian, ovary, polycystic, syndrome, tea, time, treatment, women

Denmark Gronloud such report, as paclitaxel plus platinum chemotherapy after complete remission in patients with ovarian cancer, if recurrence of a solitary lesion again cytoreductive surgery may improve survival. (Eur J Surg Oncol 2005,31:67)

In the retrospective study selected criteria: 1 Guide to the residual initial stage operation and confirmed by histological examination of epithelial ovarian cancer; (2) complete remission after first-line treatment; 3. Imaging confirmed pots peritoneal metastasis; (4) Surgical resection of lesions for the purpose.

Tags: age, cancer, cases, cell, chemotherapy, eat, examination, metastasis, ovarian, paclitaxel, patients, rate, resection, residual, study, surgery, surgical, survival, therapy, time, treatment, tumor, tumors

In recent decades, the treatment of gynecologic cancer progress has been made, but only the ovarian cancer there is no significant improvement. The incidence of ovarian cancer Habitat Gynecologic Oncology third, but it was the first fatality rate. Its cause high mortality due to the growth of ovarian cancer site concealment, not be seen directly, patients still in the early stages of the lack of simple and practical method of diagnosis. Most (about 70%) have been newly diagnosed patients with peritoneal metastasis pots. Currently taken by surgery, radiotherapy, chemotherapy and immunotherapy for the treatment of Chinese medicine integrated with the right therapy, in the treatment of advanced worse still, it is difficult to avoid recurrence. But by early diagnosis and treatment of patients with ovarian cancer prognosis is quite different. Case in epithelial ovarian cancer, according to statistics, the five-year survival rate, 80% for stage I, 40% for Stage II; While Ⅲ period just below 5%. Visibility early detection, early diagnosis and treatment of patients with ovarian cancer is a lifetime event.

Tags: abdominal, age, annex, anti, bleeding, cancer, carcinoma, cases, cause, chemotherapy, clinical, cyst, cystic, diagnosis, diet, early, eat, ert, examination, family, fat, growth, gynecological, history, incidence, increased, life, malignant, mass, metastasis, method, oppression, ovarian, pain, patients, pelvic, poor, prognosis, protein, quality, radiotherapy, rate, reduce, resection, surface, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors, women